Home Biosimilar Antibodies Proteases DPP Begelomab (Anti-DPP4 / CD26) For research use only.
Not for use in humans.

Begelomab (Anti-DPP4 / CD26)

Synonyms: SAND-26

Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.

Begelomab (Anti-DPP4 / CD26)

Purity & Quality Control

Batch: A251701 Purity: 99% Protein concentration: 12.08mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective DPP Inhibitors

Biological Activity

Description Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.

Product Details

CAS No. 1403744-56-8
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Begelomab (Anti-DPP4 / CD26) | Begelomab (Anti-DPP4 / CD26) supplier | purchase Begelomab (Anti-DPP4 / CD26) | Begelomab (Anti-DPP4 / CD26) cost | Begelomab (Anti-DPP4 / CD26) manufacturer | order Begelomab (Anti-DPP4 / CD26) | Begelomab (Anti-DPP4 / CD26) distributor